Product
Givinostat
Aliases
ITF2357
5 clinical trials
3 indications
Indication
Duchenne muscular dystrophyIndication
Drug-drug interactionsIndication
Polycythemia VeraClinical trial
Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate the Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular DystrophyStatus: Recruiting, Estimated PCD: 2028-02-01
Clinical trial
An Open-label, Single-center, Study in Healthy Subjects to Investigate the Effect of Oral Clarithromycin on the Pharmacokinetics of Givinostat (PART 2)Status: Completed, Estimated PCD: 2022-05-08
Clinical trial
Randomized, Open-label, Multicenter Phase 3 Study to Assess the Efficacy and Safety of GIVinostat Versus Hydroxyurea IN JAK2V617F-positive High-risk Polycythemia Vera Patients: the GIV-IN PV TRIALStatus: Recruiting, Estimated PCD: 2026-07-01
Clinical trial
An Open-label, Single-center, Study in Healthy Subjects to Evaluate the Plasma and Urine Pharmacokinetics of Givinostat and Its Metabolites Following Single and Multiple Oral Doses of Givinostat (Part 3).Status: Completed, Estimated PCD: 2022-05-08
Clinical trial
Open Label, Long-term Safety, Tolerability, and Efficacy Study of GIVINOSTAT in All DMD Patients Who Have Been Previously Treated in One of the GIVINOSTAT StudiesStatus: , Estimated PCD: 2025-12-01